SS-31 2S20 20mg*10vials

SS-31 2S20 20mg*10 vials (Elamipretide) is a highly effective, upgraded version of the mitochondrial-targeted antioxidant oligopeptide in the mitochondrial repair and anti-aging peptide series. It is a fortified intermediate version of the basic product, 2S10 10mg. This double-concentration version retains the unique cell-permeable structure, precise mitochondrial targeting, and unique antioxidant cardiolipin-binding repair mechanism of the SS-31 series, comprehensively enhancing mitochondrial protection, oxidative stress inhibition, and bioenergy optimization. Overcoming the limitations of the standard low-dose version's limited intervention effects, 2S20 achieves deeper mitochondrial structural repair, stronger endogenous reactive oxygen species scavenging saturation, and more thorough respiratory chain functional remodeling. It is perfectly suited for modeling moderate mitochondrial damage, high-intensity oxidative stress intervention, research on neurodegenerative diseases and cardiovascular mitochondrial damage, as well as validating the synergistic deep anti-aging effects of peptide complexes. It is a core upgraded preclinical research material for studying mitochondrial pathophysiology and efficient organ protection mechanisms.

Product Functions and Research Value

Through in-depth and systematic laboratory research, SS-31 2S20 20mg has been shown to stably anchor and bind to cardiolipin in the inner mitochondrial membrane, with significantly increased binding saturation. This significantly stabilizes mitochondrial cristae structure and membrane potential, comprehensively enhancing mitochondrial bioenergy repair efficiency. Its core upgraded research advantages encompass four enhancement dimensions: enhanced cardiolipin binding saturation to stabilize mitochondrial structure; strengthened inhibition of endogenous reactive oxygen species (ROS) sources to block deeper, persistent oxidative cascade damage; enhanced respiratory chain repair to significantly improve ATP energy synthesis efficiency; and complete inhibition of oxidation-induced apoptosis and moderate degenerative aging. Compared to the milder basal regulator 2S10, 2S20 20mg exhibits faster experimental phenotypic responses, stronger tolerance to oxidative stress thresholds, and more durable mitochondrial protective efficacy. It can potently reverse moderate mitochondrial pathological damage caused by persistent oxidation, including cristae breakage, membrane depolarization, and weakened energy metabolism. It thoroughly eliminates free radicals accumulated in cells, effectively improves cellular energy deficiency and fatigue phenotypes, and significantly reduces secondary inflammatory damage caused by mitochondrial dysfunction. Simultaneously, it also has enhanced neuroprotective and cardiovascular mitochondrial protective effects, stabilizing the physiological functions of multiple organs under mild oxidative stress. The 20mg high-efficiency balanced formulation demonstrates significant experimental variability and stable long-term efficacy output, perfectly suited for medium-to-high dose gradient threshold screening, modeling of moderate mitochondrial dysfunction mechanisms, and research on complex peptide-synergistic mitochondrial repair, providing highly discriminative and authoritative data for mitochondrial antioxidant and organ anti-aging pharmacology research.

Core Product Advantages

1. Doubled High-Efficiency Mitochondrial Targeted Repair: Based on the standard 10mg formulation, the effective concentration is doubled, significantly improving cardiolipin binding saturation and the depth of mitochondrial structural repair, completely overcoming the limitations of the limited efficacy of basic low-dose SS-31 variants.

2. Saturation Source-Level Oxidative Stress Inhibition: It has stronger endogenous ROS scavenging and oxidative cascade blocking capabilities, effectively intervening in moderate persistent oxidative damage models that cannot be fully repaired by low-dose regimens, achieving saturated mitochondrial antioxidant protection. 3. Enhanced bioenergy and multi-organ protection: Further optimizes the mitochondrial respiratory chain. 5. Advanced aseptic packaging: 10-pack integrated dust-free aseptic packaging; each batch undergoes rigorous full-item HPLC purity testing and comes with a complete official Certificate of Account (COA). It exhibits long-term stable activity retention and is widely applicable to advanced therapies.